Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs (Q35757397)
Jump to navigation
Jump to search
scientific article published on 4 May 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs |
scientific article published on 4 May 2015 |
Statements
Tumor indoleamine 2,3-dioxygenase (IDO) inhibits CD19-CAR T cells and is downregulated by lymphodepleting drugs (English)
Cliona M Rooney
Malcolm K Brenner
Helen E Heslop
Barbara Savoldo
Gianpietro Dotti
Neeharika Narala
Leslie Huye
1 reference
1 reference
1 reference
1 reference
1 reference